Response and Resistance to BCR-ABL1-Targeted Therapies

标题

作者

关键词

CML, tyrosine kinase inhibitor, targeted therapy, BCR-ABL

出版物

Volume 37, Issue 4, Pages 530-542

出版商

Elsevier BV

发表日期

2020-04-13

DOI

10.1016/j.ccell.2020.03.006

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started